Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 生命科學院
  3. 生化科技學系
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84937
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor林璧鳳(Bi-fong Lin)
dc.contributor.authorYi-Yun Yuanen
dc.contributor.author袁意雲zh_TW
dc.date.accessioned2023-03-19T22:33:43Z-
dc.date.copyright2022-08-26
dc.date.issued2022
dc.date.submitted2022-08-24
dc.identifier.citation何志剛. 2010. ‘高GABA發芽豆類篩選及促進GABA生成因子探討’ Ahn CS, Huang WW. Imiquimod in the treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2014 Oct;15(5):387-99. doi: 10.1007/s40257-014-0093-5. Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013 Apr;68(4):654-662. doi: 10.1016/j.jaad.2012.08.015. Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis Prevalence in Adults in the United States. JAMA Dermatol. 2021 Aug 1;157(8):940-946. doi: 10.1001/jamadermatol.2021.2007. Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA. 2020 May 19;323(19):1945-1960. doi: 10.1001/jama.2020.4006. Alwan W, Nestle FO. Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S2-6. Al-Harbi NO, Nadeem A, Ansari MA, Al-Harbi MM, Alotaibi MR, AlSaad AM, Ahmad SF. Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase. Int Immunopharmacol. 2017 May;46:1-8. doi: 10.1016/j.intimp.2017.02.018. Balak DM, Hajdarbegovic E. Drug-induced psoriasis: clinical perspectives. Psoriasis (Auckl). 2017 Dec 7;7:87-94. doi: 10.2147/PTT.S126727. Baroni A, Buommino E, De Gregorio V, Ruocco E, Ruocco V, Wolf R. Structure and function of the epidermis related to barrier properties. Clin Dermatol. 2012 May-Jun;30(3):257-62. doi: 10.1016/j.clindermatol.2011.08.007. Barragan A, Weidner JM, Jin Z, Korpi ER, Birnir B. GABAergic signalling in the immune system. Acta Physiol (Oxf). 2015 Apr;213(4):819-27. doi: 10.1111/apha.12467. Bateson AN. The benzodiazepine site of the GABAA receptor: an old target with new potential? Sleep Med. 2004 Jun;5 Suppl 1:S9-15. doi: 10.1016/s1389-9457(04)90002-0. Bjurstöm H, Wang J, Ericsson I, Bengtsson M, Liu Y, Kumar-Mendu S, Issazadeh-Navikas S, Birnir B. GABA, a natural immunomodulator of T lymphocytes. J Neuroimmunol. 2008 Dec15;205(1-2):44-50. doi: 10.1016/j.jneuroim.2008.08.017. Boehncke WH, Schön MP. Psoriasis. Lancet. 2015 Sep 5;386(9997):983-94. doi: 10.1016/S0140-6736(14)61909-7. Bovenschen HJ, van de Kerkhof PC, van Erp PE, Woestenenk R, Joosten I, Koenen HJ. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol. 2011 Sep;131(9):1853-60. doi: 10.1038/jid.2011.139. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med. 2004 Mar 1;199(5):731-6. doi: 10.1084/jem.20031482. Bronckers IM, Paller AS, van Geel MJ, van de Kerkhof PC, Seyger MM. Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities. Paediatr Drugs. 2015 Oct;17(5):373-84. doi: 10.1007/s40272-015-0137-1. Cellot G, Cherubini E. GABAergic signaling as therapeutic target for autism spectrum disorders. Front Pediatr. 2014 Jul 8;2:70. doi: 10.3389/fped.2014.00070. Chambers ES, Vukmanovic-Stejic M. Skin barrier immunity and ageing. Immunology. 2020 Jun;160(2):116-125. doi: 10.1111/imm.13152. Chan JR, Blumenschein W, Murphy E, Diveu C, Wiekowski M, Abbondanzo S, Lucian L, Geissler R, Brodie S, Kimball AB, Gorman DM, Smith K, de Waal Malefyt R, Kastelein RA, McClanahan TK, Bowman EP. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med. 2006 Nov 27;203(12):2577-87. doi: 10.1084/jem.20060244. Clayton K, Vallejo AF, Davies J, Sirvent S, Polak ME. Langerhans Cells-Programmed by the Epidermis. Front Immunol. 2017 Nov 29;8:1676. doi: 10.3389/fimmu.2017.01676. Denda M, Inoue K, Inomata S, Denda S. gamma-Aminobutyric acid (A) receptor agonists accelerate cutaneous barrier recovery and prevent epidermal hyperplasia induced by barrier disruption. J Invest Dermatol. 2002 Nov;119(5):1041-7. doi: 10.1046/j.1523-1747.2002.19504.x. Dhakal R, Bajpai VK, Baek KH. Production of gaba (γ - Aminobutyric acid) by microorganisms: a review. Braz J Microbiol. 2012 Oct;43(4):1230-41. doi: 10.1590/S1517-83822012000400001. Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009 Jun;129(6):1339-50. doi: 10.1038/jid.2009.59. Egeberg A, Gisondi P, Carrascosa JM, Warren RB, Mrowietz U. The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1695-1706. doi: 10.1111/jdv.16273. Eidsmo L, Martini E. Human Langerhans Cells with Pro-inflammatory Features Relocate within Psoriasis Lesions. Front Immunol. 2018 Feb 22;9:300. doi: 10.3389/fimmu.2018.00300. Ena P, Madeddu P, Glorioso N, Cerimele D, Rappelli A. High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients. Acta Cardiol. 1985;40(2):199-205. Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci. 2005 Mar;6(3):215-29. doi: 10.1038/nrn1625. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007 Jul 21;370(9583):263-271. doi: 10.1016/S0140-6736(07)61128-3. Giles AJ, Hutchinson MND, Sonnemann HM, Jung J, Fecci PE, Ratnam NM, Zhang W, Song H, Bailey R, Davis D, Reid CM, Park DM, Gilbert MR. Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. J Immunother Cancer. 2018 Jun 11;6(1):51. doi: 10.1186/s40425-018-0371-5. Goodman WA, Levine AD, Massari JV, Sugiyama H, McCormick TS, Cooper KD. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol. 2009 Sep 1;183(5):3170-6. doi: 10.4049/jimmunol.0803721. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6367-71. doi: 10.1073/pnas.86.16.6367. Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, Mehta NN, Finlay AY, Gottlieb AB. Psoriasis. Nat Rev Dis Primers. 2016 Nov 24;2:16082. doi: 10.1038/nrdp.2016.82. Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021 Apr 3;397(10281):1301-1315. doi: 10.1016/S0140-6736(20)32549-6. Guo J, Liu Y, Guo X, Meng Y, Qi C, Zhao J, Di T, Zhang L, Guo X, Wang Y, Wang Y, Li P. Depressive-like behaviors in mice with Imiquimod-induced psoriasis. Int Immunopharmacol.2020 Dec;89(Pt B):107057. doi: 10.1016/j.intimp.2020.107057. Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis. J Immunol. 2018 Sep 15;201(6):1605-1613. doi: 10.4049/jimmunol.1800013. Huang, H. Y., Hsu, T., & Lin, B. F. Gamma-aminobutyric acid decreases macrophages infiltration and suppresses inflammatory responses in renal injury. J Funct Foods.2019, 60, 103419. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995 Jun;32(6):982-6. doi: 10.1016/0190-9622(95)91336-x. Jayasingam SD, Citartan M, Thang TH, Mat Zin AA, Ang KC, Ch'ng ES. Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice. Front Oncol. 2020 Jan 24;9:1512. doi: 10.3389/fonc.2019.01512. Jin Z, Mendu SK, Birnir B. GABA is an effective immunomodulatory molecule. Amino Acids. 2013 Jul;45(1):87-94. doi: 10.1007/s00726-011-1193-7. Kaplan DH, Li MO, Jenison MC, Shlomchik WD, Flavell RA, Shlomchik MJ. Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J Exp Med. 2007 Oct 29;204(11):2545-52. doi: 10.1084/jem.20071401. Khairova RA, Machado-Vieira R, Du J, Manji HK. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol. 2009 May;12(4):561-78. doi: 10.1017/S1461145709009924. Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk Factors for the Development of Psoriasis. Int J Mol Sci. 2019 Sep 5;20(18):4347. doi: 10.3390/ijms20184347. Kanda N, Hoashi T, Saeki H. Nutrition and Psoriasis. Int J Mol Sci. 2020 Jul 29;21(15):5405. doi: 10.3390/ijms21155405. Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. 2017 Apr;63(4):278-285. Kirby B. Langerhans cells in psoriasis: getting to the core of the disease. Br J Dermatol. 2018 Jun;178(6):1240. doi: 10.1111/bjd.16596. Kowaka E, Shimajiri Y, Kawakami K, Tongu M, Akama K. Field trial of GABA-fortified rice plants and oral administration of milled rice in spontaneously hypertensive rats. Transgenic Res. 2015 Jun;24(3):561-9. doi: 10.1007/s11248-014-9859-z Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii18-23; discussion ii24-5. doi: 10.1136/ard.2004.033217. Li B, Huang L, Lv P, Li X, Liu G, Chen Y, Wang Z, Qian X, Shen Y, Li Y, Fang W. The role of Th17 cells in psoriasis. Immunol Res. 2020 Oct;68(5):296-309. doi: 10.1007/s12026-020-09149-1. Liao J, Wu X, Xing Z, Li Q, Duan Y, Fang W, Zhu X. γ-Aminobutyric Acid (GABA) Accumulation in Tea (Camellia sinensis L.) through the GABA Shunt and Polyamine Degradation Pathways under Anoxia. J Agric Food Chem. 2017 Apr 12;65(14):3013-3018. doi: 10.1021/acs.jafc.7b00304. Lin SH, Chuang HY, Ho JC, Lee CH, Hsiao CC. Treatment with TNF-α inhibitor rectifies M1 macrophage polarization from blood CD14+ monocytes in patients with psoriasis independent of STAT1 and IRF-1 activation. J Dermatol Sci. 2018 Sep;91(3):276-284. doi: 10.1016/j.jdermsci.2018.05.009. Mabunga DF, Gonzales EL, Kim HJ, Choung SY. Treatment of GABA from Fermented Rice Germ Ameliorates Caffeine-Induced Sleep Disturbance in Mice. Biomol Ther (Seoul). 2015 May;23(3):268-74. doi: 10.4062/biomolther.2015.022. Matiushenko V, Kutasevych Y, Jafferany M. Neurotransmitter imbalance in serum of psoriatic patients in exacerbation stage with comorbid psychoemotional disorders. Dermatol Ther. 2020 May;33(3):e13337. doi: 10.1111/dth.13337. Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaçi D, Behrens F, Northington R, Fuiman J, Bananis E, Boggs R, Alvarez D. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013 Nov;69(5):729-735. doi: 10.1016/j.jaad.2013.07.023. Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, Alqahtani F, As Sobeai HM, Alotaibi MR. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice. Biochimie. 2020 Dec;179:146-156. doi: 10.1016/j.biochi.2020.09.023. Nakajima H, Nakajima K, Takaishi M, Ohko K, Serada S, Fujimoto M, Naka T, Sano S. The Skin-Liver Axis Modulates the Psoriasiform Phenotype and Involves Leucine-Rich α-2 Glycoprotein. J Immunol. 2021 Apr 1;206(7):1469-1477. doi: 10.4049/jimmunol.2000502. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006 Nov;55(5):829-35. doi: 10.1016/j.jaad.2006.08.040. Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest. 2004 Jun;113(12):1664-75. doi: 10.1172/JCI22147. Oh, S. H., Moon, Y. J., & Oh, C. H. γ-Aminobutyric acid (GABA) content of selected uncooked foods.March 1, 2003. doi:10.3746/jfn.2003.8.1.075. Oh, S. H., Moon, Y. J., & Oh, C. H. (2003). γ-Aminobutyric acid (GABA) content of selected uncooked foods. Preventive Nutrition and Food Science, 8(1), 75-78. Owens DF, Kriegstein AR. Is there more to GABA than synaptic inhibition? Nat Rev Neurosci. 2002 Sep;3(9):715-27. doi: 10.1038/nrn919. Palamara F, Meindl S, Holcmann M, Lührs P, Stingl G, Sibilia M. Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod. J Immunol. 2004 Sep 1;173(5):3051-61. doi: 10.4049/jimmunol.173.5.3051. Peng H, Xian D, Liu J, Pan S, Tang R, Zhong J. Regulating the Polarization of Macrophages: A Promising Approach to Vascular Dermatosis. J Immunol Res. 2020 Jul 28;2020:8148272. doi: 10.1155/2020/8148272. Pietrzak A, Grywalska E, Socha M, Roliński J, Franciszkiewicz-Pietrzak K, Rudnicka L, Rudzki M, Krasowska D. Prevalence and Possible Role of Candida Species in Patients with Psoriasis: A Systematic Review and Meta-Analysis. Mediators Inflamm. 2018 May 6;2018:9602362. doi: 10.1155/2018/9602362. Prud'homme GJ, Glinka Y, Wang Q. Immunological GABAergic interactions and therapeutic applications in autoimmune diseases. Autoimmun Rev. 2015 Nov;14(11):1048-56. doi: 10.1016/j.autrev.2015.07.011. Rahmati, M., Blaker, J. J., Lyngstadaas, S. P., Mano, J. F., & Haugen, H. J. (2020). Designing multigradient biomaterials for skin regeneration. Materials Today Advances, 5, 100051. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta. 2001 Jan;303(1-2):33-9. doi: 10.1016/s0009-8981(00)00358-2. Sabat R, Wolk K. Research in practice: IL-22 and IL-20: significance for epithelial homeostasis and psoriasis pathogenesis. J Dtsch Dermatol Ges. 2011 Jul;9(7):518-23. English, German. doi: 10.1111/j.1610-0387.2011.07611.x. Sarasa SB, Mahendran R, Muthusamy G, Thankappan B, Selta DRF, Angayarkanni J. A Brief Review on the Non-protein Amino Acid, Gamma-amino Butyric Acid (GABA): Its Production and Role in Microbes. Curr Microbiol. 2020 Apr;77(4):534-544. doi: 10.1007/s00284-019-01839-w. Schinocca C, Rizzo C, Fasano S, Grasso G, La Barbera L, Ciccia F, Guggino G. Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview. Front Immunol. 2021 Feb 22;12:637829. doi: 10.3389/fimmu.2021.637829. Schön MP, Schön M. Imiquimod: mode of action. Br J Dermatol. 2007 Dec;157 Suppl 2:8-13. doi: 10.1111/j.1365-2133.2007.08265.x. Stratis A, Pasparakis M, Rupec RA, Markur D, Hartmann K, Scharffetter-Kochanek K, Peters T, van Rooijen N, Krieg T, Haase I. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest. 2006 Aug;116(8):2094-104. doi: 10.1172/JCI27179. Suzuki H, Wang B, Shivji GM, Toto P, Amerio P, Tomai MA, Miller RL, Sauder DN. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J Invest Dermatol. 2000 Jan;114(1):135-41. doi: 10.1046/j.1523-1747.2000.00833.x. Tan HY, Wang N, Li S, Hong M, Wang X, Feng Y. The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases. Oxid Med Cell Longev. 2016;2016:2795090. doi: 10.1155/2016/2795090. Tomi NS, Kränke B, Aberer E. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects. J Am Acad Dermatol. 2005 Jul;53(1):67-72. doi: 10.1016/j.jaad.2005.02.034. Urushima H, Fujimoto M, Mishima T, Ohkawara T, Honda H, Lee H, Kawahata H, Serada S, Naka T. Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-β-Smad2 signaling in nave helper T cells. Arthritis Res Ther. 2017 Jun 14;19(1):137. doi: 10.1186/s13075-017-1349-2. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol. 2009 May 1;182(9):5836-45. doi: 10.4049/jimmunol.0802999. Voiculescu VM, Lisievici CV, Lupu M, Vajaitu C, Draghici CC, Popa AV, Solomon I, Sebe TI, Constantin MM, Caruntu C. Mediators of Inflammation in Topical Therapy of Skin Cancers. Mediators Inflamm. 2019 Jan 10;2019:8369690. doi: 10.1155/2019/8369690. Watanabe H, Kawaguchi M, Fujishima S, Ogura M, Matsukura S, Takeuchi H, Ohba M, Sueki H, Kokubu F, Hizawa N, Adachi M, Huang SK, Iijima M. Functional characterization of IL-17F as a selective neutrophil attractant in psoriasis. J Invest Dermatol. 2009 Mar;129(3):650-6. doi: 10.1038/jid.2008.294. Yan B, Liu N, Li J, Li J, Zhu W, Kuang Y, Chen X, Peng C. The role of Langerhans cells in epidermal homeostasis and pathogenesis of psoriasis. J Cell Mol Med. 2020 Oct;24(20):11646-11655. doi: 10.1111/jcmm.15834. Yang H, Zhang W, Pan H, Feldser HG, Lainez E, Miller C, Leung S, Zhong Z, Zhao H, Sweitzer S, Considine T, Riera T, Suri V, White B, Ellis JL, Vlasuk GP, Loh C. SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activity. PLoS One. 2012;7(9):e46364. doi: 10.1371/journal.pone.0046364. Yu S, Wu X, Zhou Y, Sheng L, Jena PK, Han D, Wan YJY, Hwang ST. A Western Diet, but Not a High-Fat and Low-Sugar Diet, Predisposes Mice to Enhanced Susceptibility to Imiquimod-Induced Psoriasiform Dermatitis. J Invest Dermatol. 2019 Jun;139(6):1404-1407. doi: 10.1016/j.jid.2018.12.002. Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suárez-Fariñas M, Fuentes-Duculan J, Novitskaya I, Khatcherian A, Bluth MJ, Lowes MA, Krueger JG. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med. 2007 Dec 24;204(13):3183-94. doi: 10.1084/jem.20071094. Epub 2007 Nov 26. Zeng F, Chen H, Chen L, Mao J, Cai S, Xiao Y, Li J, Shi J, Li B, Xu Y, Tan Z, Gong F, Li B, Qian Y, Dong L, Zheng F. An Autocrine Circuit of IL-33 in Keratinocytes Is Involved in the Progression of Psoriasis. J Invest Dermatol. 2021 Mar;141(3):596-606.e7. doi: 10.1016/j.jid.2020.07.027. Zhang L, Yang XQ, Cheng J, Hui RS, Gao TW. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin Immunol. 2010 Apr;135(1):108-17. doi: 10.1016/j.clim.2009.11.008.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84937-
dc.description.abstract乾癬 (Psoriasis) 為一種由免疫失衡引發的慢性皮膚發炎疾病,且經常合併關節炎的發生,影響著全球2-3%的人口。已知gamma-胺基丁酸(Gamma-aminobutyric acid, GABA) 為一種抑制型神經傳導物質,也具有抗發炎和調節免疫的功能。在乾癬患者及乾癬動物模式中皆觀察到體內GABA含量降低,且有憂鬱的情況。因此,本研究欲利用可誘發乾癬的Imiquimod (IMQ) 建立乾癬小鼠模式,探討GABA對於乾癬病情及免疫調節的影響。實驗方法為將8週齡C57BL/6J小鼠分為四組:控制組 (Ctrl)、IMQ誘發組 (IMQ)、IMQ誘發GABA補充組 (GABA/IMQ) 和IMQ誘發Dex藥物組 (Dex/IMQ), GABA/IMQ組是餵予含500 kg/diet GABA純物質的飼料,其餘組別餵予AIN-93飼料,在第三次誘發前一週改以管餵方式給予GABA。在12週齡、20週齡以及26週齡時,分別在小鼠背部和耳朵塗抹62.5 mg和10 mg的IMQ誘發乾癬,連續塗抹5天。在第三次誘發塗抹5天共餵食18週後犧牲。結果顯示,IMQ誘發可使皮膚出現紅腫、皮屑和皮膚增厚等乾癬病徵,以及皮膚IL-17、IL-23、TNF-α和IL-10的含量上升。補充GABA可顯著降低IMQ誘導造成的背部皮膚增厚,以及IL-17的生成量。脾臟免疫分析結果顯示,IMQ也會促進脾臟細胞IL-17的分泌量,降低TNF-α、IL-6和IL-10的分泌量,但是補充GABA對於脾臟的細胞激素分泌無顯著影響。綜合上述,補充GABA可以藉由調節皮膚組織IL-17的表現量,顯著降低背部皮膚的增厚程度,具有減緩乾癬病情的潛力。zh_TW
dc.description.abstractPsoriasis is a common chronic immune-induced inflammatory skin disease, accompanied by complications such as arthritis, and affects 2-3% of the world's population. Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter, GABA also has anti-inflammatory and immune-regulating functions. In psoriasis patients and animal models, GABA levels were reduced, and depression. Therefore, we established an IMQ-induced psoriasis-like dermatitis mice model to explore the immunomodulatory effect of GABA on psoriasis mice. The eight-week-old mice were divided into four groups: Ctrl group, IMQ group, GABA/IMQ group, and Dex/IMQ group. The GABA/IMQ group was fed an AIN-93 diet containing 500 kg/diet GABA pure compound, and the other groups were fed an AIN-93 diet, GABA was given by oral gavage one week before the third induction. IMQ was applied to the back and ear of mice for 5 days to induce psoriasis at 4 weeks, 12 weeks, and 18 weeks, respectively, and sacrificed after the third induction with 18 weeks GABA supplement. The result demonstrated that IMQ induction can cause psoriasis symptoms such as erythema, scales, and thickness on the skin, increased the production of IL-17, IL-23, TNF-α, and IL-10. Back skin thickness and IL-17 production were decreased by GABA supplement. In the spleen, IMQ induction increased IL-17 secretion and decreased the secretion of TNF-α, IL-6, and IL-10. However, the levels cytokine did not show any significant difference between the GABA/IMQ group and IMQ group, showing that GABA might alleviate psoriasis by affecting the immune response in local skin rather than in peripheral immune organs.In summary, GABA alleviated skin thicknesses by regulating skin IL-17 production in the IMQ-induced psoriasis-like dermatitis mice model, which has the potential to decrease the disease degree of psoriasis.en
dc.description.provenanceMade available in DSpace on 2023-03-19T22:33:43Z (GMT). No. of bitstreams: 1
U0001-1208202211462200.pdf: 41504337 bytes, checksum: ce095cd617edd3a35e7dce7a327cad09 (MD5)
Previous issue date: 2022
en
dc.description.tableofcontents口試委員會審定書 i 謝誌 ii 摘要 iii Abstract iv 目錄 v 圖目錄 viii 縮寫對照表 x 第一章 文獻回顧 1 第一節 皮膚 1 第二節 乾癬 1 (一) 乾癬簡介 1 (二) 乾癬種類 2 (三) 乾癬機制 2 (四)、乾癬引發成因 3 (五)、乾癬的治療 4 第三節 免疫細胞在乾癬中的作用 5 (一) Th17細胞 5 (二) 巨噬細胞 6 (三) 蘭格罕細胞 7 (四) 調節型T細胞 7 第四節 細胞激素在乾癬中的作用 8 (一) IL-17A 8 (二) IL-17F 8 (三) IL-22 8 (四) IL-21 9 (五) IL-23 9 第五節 乾癬動物模式 10 (一) Imiquimod誘發乾癬 10 (二) 其他 10 第六節 Gamma-aminobutyric acid 11 (一) Gamma-aminobutyric acid簡介 11 (二) GABA與免疫調節 12 (三) GABA與乾癬的相關研究 12 (四) GABA與其他疾病的相關研究 13 第七節 研究動機與目的 14 第二章 實驗設計與材料方法 15 第一節 實驗設計 15 第二節 動物飼養 16 一、建立IMQ誘發的乾癬小鼠模式 16 第三節 實驗方法 18 一、皮膚組織切片染色 18 二、皮膚組織細胞激素含量分析 18 三、脾臟淋巴細胞分離與培養 19 四、脾臟免疫細胞表型分析 20 五、血清GABA含量 22 六、統計分析 22 第三章 實驗結果 23 一、IMQ誘導乾癬小鼠體重和攝食量 23 二、IMQ誘導乾癬小鼠組織器官重 24 三、GABA對IMQ誘導乾癬小鼠的皮膚乾癬症狀之影響 25 四、GABA對IMQ誘導乾癬小鼠的皮膚增厚程度之影響 28 五、GABA對IMQ誘導乾癬小鼠免疫細胞分泌細胞激素之影響 29 六、GABA對IMQ誘導乾癬小鼠皮膚的細胞激素濃度 30 七、GABA對IMQ誘導乾癬小鼠脾臟中T細胞數目的影響 31 八、IMQ誘導乾癬小鼠血清中GABA含量 32 九、IMQ誘導乾癬小鼠脾臟細胞激素相關性 33 十、IMQ誘導乾癬小鼠皮膚與脾臟細胞激素之相關性 34 十一、IMQ誘導乾癬小鼠皮膚細胞激素之相關性 35 十二、IMQ誘導乾癬小鼠皮膚以及脾臟細胞激素與皮膚增厚程度之相關性 36 第四章 討論與結論 37 第一節 討論 37 一、IMQ誘導乾癬小鼠模式探討 37 二、GABA對IMQ誘導乾癬小鼠皮膚損傷之影響 38 三、GABA對IMQ誘導乾癬小鼠脾臟分泌細胞激素之影響 39 四、GABA對IMQ誘導乾癬小鼠皮膚細胞激素之影響 40 五、補充GABA對IMQ誘導乾癬小鼠血清GABA含量之影響 41 六、未來展望 41 第二節 結論 42 附錄表 43 參考文獻 45
dc.language.isozh-TW
dc.subjectIL-17zh_TW
dc.subjectgamma-胺基丁酸zh_TW
dc.subject乾癬zh_TW
dc.subject咪喹莫特zh_TW
dc.subjectImiquimoden
dc.subjectIL-17en
dc.subjectgamma-aminobutyric aciden
dc.subjectpsoriasisen
dc.title探討gamma-胺基丁酸對Imiquimod誘發乾癬小鼠免疫調節之影響zh_TW
dc.titleEffects of gamma-aminobutyric acid on immunomodulation in IMQ-induced psoriasis-like dermatitis miceen
dc.typeThesis
dc.date.schoolyear110-2
dc.description.degree碩士
dc.contributor.oralexamcommittee江孟燦(Meng-Tsan Chiang),江伯倫(Bor-Luen Chiang),何佳安(Ja-An Ho),陳俊任(Chun-Jen Chen)
dc.subject.keywordgamma-胺基丁酸,乾癬,咪喹莫特,IL-17,zh_TW
dc.subject.keywordgamma-aminobutyric acid,psoriasis,Imiquimod,IL-17,en
dc.relation.page52
dc.identifier.doi10.6342/NTU202202334
dc.rights.note同意授權(限校園內公開)
dc.date.accepted2022-08-24
dc.contributor.author-college生命科學院zh_TW
dc.contributor.author-dept生化科技學系zh_TW
dc.date.embargo-lift2022-08-26-
顯示於系所單位:生化科技學系

文件中的檔案:
檔案 大小格式 
U0001-1208202211462200.pdf
授權僅限NTU校內IP使用(校園外請利用VPN校外連線服務)
40.53 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved